First-line escalated BEACOPP does not hinder stem cell collection and transplantation strategy in patients with relapsed/refractory Hodgkin's lymphoma

D. Ghez (1, 2) , C. Fortpied (3) , N. Mounier (4) , P. Carde (1) , A. Perrot (5) , H. Khaled (6) , S. Amorim (7, 8) , S. Ramadan (3) , F. L. Bras (9) , M. Erlanson (10) , C. Herbaux (11, 12) , J-P Marolleau (13) , E. Nicolas-Virelezier (14) , O. Casasnovas (15) , A. Stamatoullas-Bastard (16) , C. Ferme (1)

1 IGR - Institut Gustave Roussy
2 Département d'hématologie [Gustave Roussy]
3 EORTC Headquarters [Brussels, Belgium]
4 CHU - Hôpital Archet 2 [Nice]
5 Service d’Hématologie Adulte [Hôpitaux de Brabois, CHU Nancy]
6 National Cancer Institute, Cairo University
7 Service d'hématologie adulte [Hôpital de Saint Louis]
8 UPD7 - Université Paris Diderot - Paris 7
9 Hôpital Henri Mondor
10 Umeå University
11 Hôpital Claude Huriez [Lille]
12 Université de Lille
13 Laboratoire d'Hématologie [CHU Amiens]
14 Centre Léon Bérard [Lyon]
15 Service d'Hématologie Clinique (CHU de Dijon)
16 CLCC Henri Becquerel - Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen

No abstract available

Domaines: Sciences du Vivant [q-bio]

D. Ghez, C. Fortpied, N. Mounier, P. Carde, A. Perrot, et al.. First-line escalated BEACOPP does not hinder stem cell collection and transplantation strategy in patients with relapsed/refractory Hodgkin's lymphoma. Bone Marrow Transplantation, 2017, 52 (2), pp.310-312. ⟨10.1038/bmt.2016.271⟩. ⟨hal-03605050⟩